We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
GoPower offers comprehensive portable solar energy solutions, designed to save you money and reduce your environmental impact. Their user-friendly solar panels eliminate the need for complex installations, allowing easy setup anywhere. Their portable solar power stations, providing up to 1000w/1280WH at 240v, are perfect for various applications such as home offices, garden rooms, boats, events, and more. With multiple output sockets and versatile charging options including solar panels and mains electricity, GoPower provides a greener and cost-effective energy alternative.
days to go: Extended investment: £10,000
Rype addresses the dilemma of choosing between expensive or low-quality office furniture that contributes to carbon emissions and waste. By remanufacturing high-quality used office furniture, Rype offers cost-effective solutions with 80% lower carbon emissions and waste, while creating local jobs. Their mission is to significantly reduce office carbon emissions and costs through sustainable, circular economy practices, including exclusive furniture ranges made from waste materials. Rype's comprehensive services encompass furniture sourcing, remanufacturing, and employing marginalized individuals, contributing to a more environmentally friendly and socially responsible approach to office furnishings.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Kindred is a social enterprise platform working with 25,000 brands and helping over 25,000 charities online through conscious consumption. It has built a browser extension and mobile app that allows consumers to shop online, get discounts, earn cash back and donate a percentage of that cash back to a chosen charity all on one single portal. The company asserts that charities are experiencing a 48% drop in donations in the wake of COVID-19. Since Kindred's launch in March 2020, customers have bought products worth over £3.3 million. The company aims to be a major contender in the social enterprise category. Kindred has raised over £470,000 for charity in 6 months. It has also raised a seed funding of £2.1 million in 2019. The company will use the investment to scale its operations.
days to go: Expired investment: £406,816
Riversimple is a car manufacturer and service provider that aims to usher in path-breaking electric vehicles that run on Hydrogen on a subscription basis. Customers are required to pay a single monthly fee that covers the vehicle, fuel, maintenance, and insurance costs. Riversimple claims that its proprietary two-seat local commuter vehicle, Rasa, can cover nearly 300 miles from a 3-minute fill. The company has signed an agreement with Siemens UK to collaborate over technology and sustainability. Riversimple asserts that Siemens is helping design the volume manufacturing facility. The company points out that it is leading the Circular Revolution, a £2.3 million programme part-funded by the European Regional Development Fund (ERDF), to introduce a circular economy practice in businesses in Wales and to facilitate circular economy innovation in the supply chain. It will use the investment to expand its engineering team, channel customer feedback into the designs for volume production, and deliver the most efficient facility possible.
days to go: Expired investment: £1,316,352
Propelair is a company that has developed the world’s lowest water-flush toilet system. The toilet uses air to propel 1.5 litres of water per flush, saving water when compared to 6-9 litres per flush for conventional toilets. The company has installed nearly 4,000 units in the UK and South Africa. They were awarded the prestigious Horizon2020 grant in 2017 to develop new innovations. It has also been featured in publications such as The Daily Telegraph, London Evening Standard, and The Times. The company will use the investment as working capital and stock acquisition funds to enable growth, in the UK and South Africa and launch into other water-stressed markets like the Middle East, Australia, Hong Kong, and Singapore, and introduce its 'Smart Connected Toilet' to the market. 

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £1,236,245
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph